PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,371,402 | -23.0% | 10,224,120 | +22.6% | 0.43% | -25.7% |
Q2 2023 | $110,896,996 | +50.7% | 8,338,120 | +31.2% | 0.58% | +41.5% |
Q1 2023 | $73,592,290 | +124.7% | 6,355,120 | +58.7% | 0.41% | +108.7% |
Q4 2022 | $32,755,992 | +120.6% | 4,004,400 | +145.4% | 0.20% | +170.8% |
Q1 2022 | $14,849,000 | -64.5% | 1,631,800 | -20.2% | 0.07% | -65.6% |
Q4 2021 | $41,851,000 | -17.8% | 2,045,488 | +2.7% | 0.21% | -12.2% |
Q3 2021 | $50,902,000 | +482.2% | 1,992,250 | +696.9% | 0.24% | +561.1% |
Q2 2021 | $8,743,000 | -84.0% | 250,000 | -88.1% | 0.04% | -89.0% |
Q4 2020 | $54,474,000 | +35.8% | 2,100,000 | -48.3% | 0.33% | +18.4% |
Q3 2020 | $40,109,000 | +287.5% | 4,063,770 | +35.5% | 0.28% | +233.7% |
Q2 2020 | $10,350,000 | +12.7% | 3,000,000 | 0.0% | 0.08% | +5.1% |
Q1 2020 | $9,180,000 | -40.5% | 3,000,000 | 0.0% | 0.08% | -24.0% |
Q4 2019 | $15,420,000 | – | 3,000,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |